Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Nov 2005

Nishiyama Masahiko

Abstract excerpt

Pharmacogenomics is a large-scale systematic approach using a variety of genomic technologies to discover drug response determinants and promote a better understanding of the genetic and molecular basis underlying variable drug response among patients. However, few critical prediction markers of drug response have been validated to date. Drug sensitivity is determined by multiple genes:drugs are often involved in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Dihydrouracil Dehydrogenase (NADP)
Share to Drug Screening Assays, Antitumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fluorouracil

Share to Gene Expression Regulation, Neoplastic

Share to Genome, Human

Share to Oligonucleotide Array Sequence Analysis

Share to Pharmacogenetics

Source

Identifiers

PMID: 16282724

Genes

DPYD

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Polygenetic pharmacogenomic strategies to identify drug sensitivity biomarkers].PMID 16282724Read ↗

Systematic identification of genomic markers of drug sensitivity in cancer cellsSemantic proximity Read ↗

Comprehensive signature analysis of drug metabolism differences in the White, Black and Asian prostate cancer patients.Semantic proximity Read ↗

Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells.Semantic proximity Read ↗

Cancer pharmacogeneticsSemantic proximity Read ↗

An integrative resource for investigating genetic model of drug response in cancerSemantic proximity Read ↗

Pharmacogenomics panel test for prevention toxicity in patient who receive Fluoropirimidine/Oxaliplatin-based therapy.Semantic proximity Read ↗

[A new approach to pharmacogenomics].Semantic proximity Read ↗

Drug Sensitivity Prediction From Cell Line-Based Pharmacogenomics Data: Guidelines for Developing Machine Learning ModelsSemantic proximity Read ↗

DROEG: a method for cancer drug response prediction based on omics and essential genes integrationSemantic proximity Read ↗

Cancer pharmacogenomics: DNA genotyping and gene expression profiling to identify molecular determinants of chemosensitivity.Semantic proximity Read ↗

The use of genomic information to optimize cancer chemotherapy.Semantic proximity Read ↗

Pharmacogenetics of Anticancer Drug Sensitivity and Toxicity in Colorectal Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.